ASPI Stock Overview
A development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 2/6 |
Past Performance | 0/6 |
Financial Health | 5/6 |
Dividends | 0/6 |
ASP Isotopes Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$3.49 |
52 Week High | US$5.67 |
52 Week Low | US$0.58 |
Beta | 0 |
11 Month Change | -10.51% |
3 Month Change | 14.80% |
1 Year Change | 384.65% |
33 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | 30.71% |
Recent News & Updates
Recent updates
Shareholder Returns
ASPI | US Chemicals | US Market | |
---|---|---|---|
7D | 13.3% | 2.1% | 1.3% |
1Y | 384.7% | 3.0% | 22.0% |
Return vs Industry: ASPI exceeded the US Chemicals industry which returned 3% over the past year.
Return vs Market: ASPI exceeded the US Market which returned 22% over the past year.
Price Volatility
ASPI volatility | |
---|---|
ASPI Average Weekly Movement | 12.5% |
Chemicals Industry Average Movement | 5.0% |
Market Average Movement | 5.8% |
10% most volatile stocks in US Market | 14.8% |
10% least volatile stocks in US Market | 2.8% |
Stable Share Price: ASPI's share price has been volatile over the past 3 months.
Volatility Over Time: ASPI's weekly volatility (12%) has been stable over the past year, but is still higher than 75% of US stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2021 | 76 | Paul Mann | aspisotopes.com |
ASP Isotopes Inc., a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235.
ASP Isotopes Inc. Fundamentals Summary
ASPI fundamental statistics | |
---|---|
Market cap | US$252.52m |
Earnings (TTM) | -US$19.62m |
Revenue (TTM) | US$1.27m |
180.7x
P/S Ratio-11.7x
P/E RatioIs ASPI overvalued?
See Fair Value and valuation analysisEarnings & Revenue
ASPI income statement (TTM) | |
---|---|
Revenue | US$1.27m |
Cost of Revenue | US$855.54k |
Gross Profit | US$417.84k |
Other Expenses | US$20.04m |
Earnings | -US$19.62m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | -0.30 |
Gross Margin | 32.81% |
Net Profit Margin | -1,540.72% |
Debt/Equity Ratio | 170.6% |
How did ASPI perform over the long term?
See historical performance and comparison